Interestingly, SNRPA1 could regulate the infiltration of most immune cell types in BRCA, LIHC, LUAD, THCA, and THYM, which indicated that SNRPA1 could be treated as a promising target to regulate tumor immunity in those cancer types (Figure 7C). The gene discussed is SNRPA1; the disease is neoplasm.